Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Treatment-resistant panic disorder.

Borwin Bandelow1, Eckart Rüther

  • 1Department of Psychiatry and Psychotherapy, University of Göttingen, Germany. bbandel@gwdg.de

CNS Spectrums
|September 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment of posttraumatic stress disorder (PTSD).

Dialogues in clinical neuroscience·2026
Same author

Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Associations of lifestyle factors with amyloid pathology in persons without dementia.

Journal of Alzheimer's disease : JAD·2025
Same author

Comparative efficacy and acceptability of anxiolytic drugs for the treatment of anxiety disorders: a systematic review and network meta-analysis.

European archives of psychiatry and clinical neuroscience·2025
Same author

Depressive Symptoms and Amyloid Pathology.

JAMA psychiatry·2025

Many patients with panic disorder and agoraphobia do not fully respond to initial treatments. This review offers guidance on alternative pharmacologic and cognitive-behavioral therapies for treatment-resistant cases.

Area of Science:

  • Psychiatry
  • Clinical Pharmacology

Background:

  • Panic disorder and agoraphobia often require ongoing management.
  • Standard treatments like SSRIs, TCAs, benzodiazepines, and MAOIs are not universally effective.

Purpose of the Study:

  • To provide treatment recommendations for patients with panic disorder and agoraphobia unresponsive to standard pharmacotherapy.
  • To define criteria for nonresponse to drug treatment.

Main Methods:

  • Review of existing studies on treatment-resistant panic disorder and agoraphobia.
  • Definition of nonresponse: failure to achieve a 50% symptom reduction after 6 weeks of adequate dosing.

Main Results:

  • Consider switching to alternative standard medications when initial treatments fail.

Related Experiment Videos

  • Investigate novel agents like venlafaxine and combination therapies (e.g., SSRI + benzodiazepine).
  • Cognitive-behavioral therapy (CBT) is recommended for all patients.

    • Conclusions:

    • Combined pharmacologic treatment with CBT is recommended for nonresponders.
    • A systematic approach to medication changes and the integration of psychotherapy are crucial for optimizing outcomes.